Abstract Body

By simultaneously determining millions or billions of individual nucleic acid sequences in a single experiment, next-generation sequencing technologies allow the analysis of rare events even in the context of very large populations. Therefore, these technologies can help facilitate study of HIV genetic variants or HIV-infected cells within highly heterogeneous ex vivo samples from HIV-positive individuals. This talk will consider the application of this experimental approach to key questions in basic and translational HIV research. Specific examples to be discussed include the detection of antiviral drug-resistant virus variants in people not yet treated with drug, and the comprehensive characterization of HIV-infected cellular reservoirs in blood and tissues by single-cell whole transcriptome sequencing. The purpose of this discussion is to update the audience on ongoing work in the field and to prompt consideration of other uses for next-generation sequencing in HIV prevention and therapy studies.